Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Adaptive Biotechnologies ...

    NASDAQ: ADPT · Real-Time Price · USD
    10.26
    -0.03 (-0.29%)
    At close: Jun 17, 2025, 10:28 AM

    Adaptive Biotechnologies Statistics

    Share Statistics

    Adaptive Biotechnologies has 151.92M shares outstanding. The number of shares has increased by 0.82% in one year.

    Shares Outstanding

    n/a
    		 151.92M

    Shares Change (YoY)

    n/a
    		 0.82%

    Shares Change (QoQ)

    n/a
    		 0.68%

    Owned by Institutions (%)

    n/a
    		 97.14%

    Shares Floating

    n/a
    		 144.91M

    Failed to Deliver (FTD) Shares

    n/a
    		 3,115

    FTD / Avg. Volume

    n/a
    		 0.15%

    Short Selling Information

    The latest short interest is 9.64M, so 6.35% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 9.64M

    Short % of Shares Out

    n/a
    		 6.35%

    Short % of Float

    n/a
    		 8.13%

    Short Ratio (days to cover)

    n/a
    		 7.93

    Valuation Ratios

    The PE ratio is -5.53 and the forward PE ratio is -15.86. Adaptive Biotechnologies's PEG ratio is 0.18.

    PE Ratio

    n/a
    		 -5.53

    Forward PE

    n/a
    		 -15.86

    PS Ratio

    n/a
    		 4.93

    Forward PS

    n/a
    		 4.3

    PB Ratio

    n/a
    		 4.35

    P/FCF Ratio

    n/a
    		 -8.93

    PEG Ratio

    n/a
    		 0.18
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Adaptive Biotechnologies.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.89, with a Debt / Equity ratio of 0.44.

    Current Ratio

    n/a
    		 2.89

    Quick Ratio

    n/a
    		 2.81

    Debt / Equity

    n/a
    		 0.44

    Debt / EBITDA

    n/a
    		 -0.69

    Debt / FCF

    n/a
    		 -0.9

    Interest Coverage

    n/a
    		 -14.04

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $289,106.62

    Profits Per Employee

    n/a
    		 $-257,660.74

    Employee Count

    n/a
    		 619

    Asset Turnover

    n/a
    		 0.33

    Inventory Turnover

    n/a
    		 8.54

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 226.75% in the last 52 weeks. The beta is 1.79, so Adaptive Biotechnologies's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.79

    52-Week Price Change

    n/a
    		 226.75%

    50-Day Moving Average

    n/a
    		 8.81

    200-Day Moving Average

    n/a
    		 6.91

    Relative Strength Index (RSI)

    n/a
    		 63.24

    Average Volume (20 Days)

    n/a
    		 2,144,044

    Income Statement

    In the last 12 months, Adaptive Biotechnologies had revenue of 178.96M and earned -159.49M in profits. Earnings per share was -1.08.

    Revenue

    n/a
    		 178.96M

    Gross Profit

    n/a
    		 106.88M

    Operating Income

    n/a
    		 -162.55M

    Net Income

    n/a
    		 -159.49M

    EBITDA

    n/a
    		 -128.76M

    EBIT

    n/a
    		 -148.01M

    Earnings Per Share (EPS)

    n/a
    		 -1.08
    Full Income Statement

    Balance Sheet

    The company has 47.92M in cash and 89.39M in debt, giving a net cash position of -41.47M.

    Cash & Cash Equivalents

    n/a
    		 47.92M

    Total Debt

    n/a
    		 89.39M

    Net Cash

    n/a
    		 -41.47M

    Retained Earnings

    n/a
    		 -1.3B

    Total Assets

    n/a
    		 510.85M

    Working Capital

    n/a
    		 168.68M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -95.21M and capital expenditures -3.66M, giving a free cash flow of -98.88M.

    Operating Cash Flow

    n/a
    		 -95.21M

    Capital Expenditures

    n/a
    		 -3.66M

    Free Cash Flow

    n/a
    		 -98.88M

    FCF Per Share

    n/a
    		 -0.67
    Full Cash Flow Statement

    Margins

    Gross margin is 59.72%, with operating and profit margins of -90.83% and -89.12%.

    Gross Margin

    n/a
    		 59.72%

    Operating Margin

    n/a
    		 -90.83%

    Pretax Margin

    n/a
    		 -89.18%

    Profit Margin

    n/a
    		 -89.12%

    EBITDA Margin

    n/a
    		 -71.95%

    EBIT Margin

    n/a
    		 -90.83%

    FCF Margin

    n/a
    		 -55.25%

    Dividends & Yields

    ADPT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ADPT is $9.5, which is -7.4% lower than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $9.5

    Price Target Difference

    n/a
    		 -7.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -1.17

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist